A clinical trial to study the effect of two drugs oxytocin and carbetocin in management of third stage of labour in vaginal deliveries
Phase 3
- Conditions
- Health Condition 1: O720- Third-stage hemorrhage
- Registration Number
- CTRI/2024/05/066832
- Lead Sponsor
- Rajendra institute of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All women undergoing vaginal delivery
Exclusion Criteria
Women who undergo caesarean section
Women with proven hypersensitivity to oxytocin and carbetocin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Postpartum haemorrhage more than 500 ml blood lossTimepoint: Postpartum haemorrhage more than 500 ml blood loss
- Secondary Outcome Measures
Name Time Method eed for blood Transfusion and fall in hemoglobin levelsTimepoint: Hemoglobin fall more than 1 gm/dl